Kepler Cheuvreux lifts target for DSM-Firmenich stock to EUR 100.00

Published on 10/16/2026 at 15:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

An extraordinary meeting is scheduled for October 19, 2026. DSM-Firmenich stock costs EUR 107.45 on October 16, 2026, unchanged versus the Euronext close.

Analyst target and market dates

Kepler Cheuvreux raised its DSM-Firmenich target to EUR 100.00 on September 29, 2026, leaving it 6.93 percent below the price.
An extraordinary general meeting is scheduled for October 19, 2026.
DSM-Firmenich stock costs EUR 107.45 at Lang & Schwarz on October 16, 2026 at 3:37 p.m. CEST and is unchanged versus the Euronext Amsterdam close of October 15, 2026.
Symrise trades at a P/E ratio of 37.61 with a market capitalization of EUR 13.7 billion.

Isometrische 3D-Grafik der Wertschöpfungskette von Rohstoff bis Vertrieb — dsm-firmenich AG (ISIN CH1216478797) veranschaulicht ihre Wertschöpfungskette von Rohstoffen bis Vertrieb als isometrische 3D-Grafik, Illustration mit AI erstellt.

Kepler Cheuvreux raised its target for DSM-Firmenich from EUR 67.00 to EUR 100.00 on September 29, 2026, while retaining a Hold view, according to Ideal Investisseur. The new target is 6.93 percent below the Lang & Schwarz price. DSM-Firmenich stock was trading at EUR 107.45 at Lang & Schwarz on October 16, 2026 at 3:37 p.m. CEST, unchanged versus the Euronext Amsterdam close of October 15, 2026.

Meeting date arrives next

An extraordinary general meeting is scheduled for October 19, 2026. The date appears in a calendar published by FinanzNachrichten. For investors, the meeting is the next dated corporate item after the target revision.

Price position and valuation

The current euro quotation is 0.00 percent above or below the Euronext Amsterdam close used for the session comparison. The Lang & Schwarz bid was EUR 107.40 and the ask was EUR 107.50 at 3:37 p.m. CEST. The narrow EUR 0.10 spread places the market indication around the quoted level.

DSM-Firmenich had a market capitalization of EUR 26.2 billion and a negative trailing P/E ratio of minus 22.25 as of October 16, 2026. The valuation figure reflects the latest available earnings basis rather than a forward estimate. The stock's current level is also EUR 7.45 above the Kepler Cheuvreux target of EUR 100.00.

Comparison with peers

DSM-Firmenich (Euronext Amsterdam, EUR): unchanged, P/E minus 22.25, market capitalization EUR 26.2 billion.

Symrise (Xetra, EUR): up 0.80 percent, P/E 37.61, market capitalization EUR 13.7 billion.

International Flavors & Fragrances (NYSE, USD): up 1.26 percent, P/E 84.71, market capitalization USD 23.3 billion.

Stock stays near the latest quote

The analyst target and the upcoming meeting provide two dated reference points for the stock, while the market quotation itself was unchanged against the Euronext Amsterdam close. The next session will show whether the share price remains above the revised target.

The further course of trading is shown by the continuously updated real-time quote of DSM-Firmenich stock.